Chantix
Product Images NDC 50090-0998

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 50090-0998). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chantix 01)

Chemical structure diagram showing the molecular structure of CHANTIX's active ingredient. The diagram includes atoms connected by bonds, featuring rings and functional groups typical of the molecule's arrangement.*

FDA Label Image

Figure 1 (Chantix 02)

A bar chart comparing the efficacy outcomes of different dosing regimens of CHANTIX (0.5 mg BID and 1.0 mg BID), CHANTIX IFX flexible dosing, bupropion SR 150 mg BID, and placebo across five studies. Each study group shows percentage values with error bars representing variability.*

FDA Label Image

Figure 2 (Chantix 03)

A bar chart comparing percentages across five studies showing the effects of CHANTIX (0.5 mg BID and 1.0 mg BID), flexible CHANTIX dosing, bupropion SR 150 mg BID, and placebo. Each study groups treatments with vertical separators and includes error bars indicating variability. The y-axis represents the percentage values from 0% to 35%.*

FDA Label Image

Figure 3 (Chantix 04)

A line graph comparing CHANTIX 1.0 mg BID with placebo over nontreatment follow-up weeks. The y-axis shows the percentage of continuous abstinent individuals, while the x-axis shows weeks of follow-up. CHANTIX demonstrates a higher percentage of continuous abstinence compared to placebo throughout the follow-up period.*

FDA Label Image

Logo (Chantix 05)

FDA Label Image

Chantix 06

FDA Label Image

Label Image (Lbl500900998)

The packaging label for CHANTIX by A-S Medication Solutions shows the NDC number 50090-0998-0. It includes tablet strength information, dosage instructions indicating 11 tablets per pack for 3 weeks, and mentions varenicline base equivalent as the active ingredient. The label also features manufacturer details including Pfizer Labs and a 25 mg tablet strength.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.